CELF1 and hepatocellular carcinoma: Our results demonstrate that a calcium channel blocker BK10007S exerted cytotoxic and anti-proliferative effects, increased sub G1 population and induced apoptosis via inhibition of CUGBP1 and activation of caspases in HepG2 and SK-Hep1 hepatocellular carcinomas.